AI in GxP - QFINITY
AI · GxP · Digital Compliance

Artificial intelligence in the GxP environment

QFINITY helps regulated organizations put AI to work in GxP environments without losing auditability and control. That way, AI is part of an auditable, integrated overall system - not a standalone technology project.

The shift

Understanding what AI really changes in regulated environments.

Artificial intelligence is reshaping pharma, biotechnology and medical technology - and not only on a technical level. It changes processes, how decisions are made and where accountability sits - and, in turn, how control, evidence and trust have to be organized. AI is currently the most visible part of the digital transformation in GxP-regulated fields - the foundation is digital compliance.

That is why, in a GxP-regulated environment, it is not enough to treat AI as just another piece of software. AI can reach into data flows, assessments, decisions and control structures that bear directly on patient safety, product quality and data integrity.

EU AI Act GAMP 5 GAMP AI CSV / CSA ALCOA++ Human Oversight Intended Use Risk-based Lifecycle Evidence
Look only at the model and you are looking at too little. Treat AI as just another feature and you underestimate what it does.
The core

AI in the GxP environment is more than an application.

In regulated environments, AI is rarely a system in its own right. We treat AI as a subsystem of a larger computerized system - its real impact comes from how it interacts with processes, data, roles, interfaces, suppliers and human decisions.

It only holds up when you look at the relevant elements together:

AI models and algorithms
IT systems, platforms, infrastructure and interfaces
Business processes and SOPs
Data quality and data integrity
IT and information security
Roles, responsibilities and governance structures
Staff qualification and human judgment
Development, change and operational processes
Supplier management and contractual transparency
Monitoring, change control and Lifecycle Evidence
Governance architecture

Two regulatory logics, one architecture.

Any AI deployment in a GxP environment has to be assessed from two angles: the GxP risk assessment and the risk classification under the EU AI Act. The two are not the same - and should not be run as separate, parallel compliance tracks, but as a single, coherent governance and lifecycle architecture: separate tracks are error-prone and resource-intensive.

AspectGxP risk assessmentEU AI Act
Key questionWhat is the impact on patient safety, product quality and data integrity?Which risk class does the AI system fall into, given its intended purpose?
Basis for classificationCriticality of the process, the data flow and the system's influence on decisionsIntended purpose, area of use and potential impact
What triggers requirementsA risk-based decision on validation, controls, monitoring and evidenceAdditional requirements depending on the AI system's risk class
Reference frameworkGxP regulations; methodically: GAMP 5, GAMP AI, CSV / CSA, Data Integrity, QMSThe EU AI Act within the family of harmonized EU regulation - including MDR/IVDR and the Machinery Regulation, along with horizontal legislation such as the GDPR
How they relateCan be critical without triggering the same classification under the AI ActCan trigger requirements that then have to be built into GxP, CSV / CSA and Data Integrity structures

An AI application can be critical from a GxP standpoint without automatically carrying the same classification under the EU AI Act - and vice versa. The aim is not to build two separate tracks, but a single architecture in which both lines of reasoning work together coherently.

Practical experience

Practical experience from real-world AI use cases.

QFINITY supports AI initiatives in regulated environments. What counts is whether AI can affect GxP-relevant data, processes, assessments or decisions - and the greater that influence, the higher the bar for governance, validation, Human Oversight, monitoring and evidence.

AI-supported image analysis in clinical applications
visual inspection and in-line checks in pharmaceutical manufacturing
data-driven process optimization and yield improvement
generative AI applications in deviation management
LLM-based support in pharmacovigilance and regulatory operations
post-market surveillance in medical technology
embedded AI features in SaaS, cloud and platform solutions
Machine Learning Generative AI Agentic AI LLMs
Sound AI deployment

Three dimensions of sound AI deployment.

Deploying AI dependably in a GxP environment means working through three dimensions in turn: understand it, take ownership of it, demonstrate it. CSV stays the foundation - but for AI-supported computerized systems it has to be extended to cover data, model behavior, drift and Lifecycle Evidence. This reading is not desk theory: QFINITY works on exactly these questions in the ISPE AI Community of Practice and the GAMP AI Special Interest Groups.

  1. 1

    Understand

    What does the system do, what is it used for, which business process does it act in, which data does it draw on, which decision does it shape, and where do its boundaries lie? Without that context, AI is just a technical function with no sound regulatory footing.

  2. 2

    Take ownership

    Who decides, who reviews, who can object, who can override, and who is ultimately accountable? Human Oversight does not mean a person appears somewhere in the process - it means human judgment stays visible, can actually be exercised and can be verified.

  3. 3

    Demonstrate

    Which evidence holds up across the lifecycle? Which data, tests, controls, monitoring results and change assessments show that the system is - and stays - fit for its Intended Use? In an audit, what matters is not whether AI looks modern, but whether control, accountability and evidence can be explained convincingly.

QFINITY approach

AI, GxP compliance and Lifecycle Evidence as an integrated whole.

Our approach starts not with the tool, but with where the system sits in regulatory and process terms. That gives you a solid basis for deciding how to introduce, govern, monitor and operate AI-enabled systems - and how to validate the computerized systems they are embedded in.

  • Intended Use & Business Process

    What the system is used for and which business process it acts in - the starting point for any regulatory assessment.

  • Data flow

    Which data the system uses, where it comes from and how it moves through the regulated process.

  • Decision influence

    How far an output prepares, influences or displaces human judgment - and what controls that calls for.

  • Risk to GxP-protected assets

    Impact on patient safety, product quality and data integrity - the measure for how much effort is warranted.

  • Responsibilities

    Clear roles for deciding, reviewing, objecting and overriding - Human Oversight that holds up in an audit.

  • Controls & Lifecycle Evidence

    The controls you need and audit readiness, evidenced continuously across the entire lifecycle.

In-depth pages

Go deeper.

Client voices

QFINITY supported us as a partner for CSV, CSA and AI in GxP throughout the development of Tenthpin Intelligent Certificate VerificAItion (T/ICV), our cloud-based, AI-driven certificate verification solution. Quality assurance and auditability were not treated as an afterthought but embedded in the agile development process from the outset: risk-based assurance, human in the loop as a design principle, quality oversight with clearly assigned responsibility. The result is a GxP-ready AI system with robust lifecycle evidence on which our customers can build their validation.

TW
Thomas Weber
Chief Product Officer - Tenthpin Solutions, Switzerland

As a truly AI-native startup in the patient safety space, where there's no margin for error, we brought QFINITY in at the very start to help build our QMS from the ground up. Their guidance provided a framework that held up under scrutiny as we secured early adopters. We've since passed comprehensive client vendor audits, including leading CRO's, with zero major or critical findings, and are supporting client regulatory inspections. Quality is a competitive advantage, not a compliance tax.

AM
Andrew Mitchell
AI for Pharmacovigilance / Patient Safety - YEZA.AI, USA

Position your AI initiative on solid regulatory ground in the GxP environment.

We assess your AI initiative along its Intended Use, data flow, decision influence and GxP risk, and hand you a sound basis for decisions on validation, governance and evidence. The intro call is free and runs about 30 minutes.

Book an intro call
FAQ

Still have questions?

In the GxP environment, AI can have a direct or indirect impact on patient safety, product quality and data integrity. That is why a purely technical assessment falls short. AI has to be assessed within its specific process - taking in its Intended Use, the data it relies on, its influence on decisions and the controls around it.

CSV stays the foundation, but for AI-supported computerized systems it is often not enough on its own. You also need to address data quality, model behavior, monitoring, drift, re-validation, governance and Human Oversight.

The EU AI Act regulates AI applications broadly, across industries. Classification and risk categorization can trigger further requirements depending on intended purpose, area of use or impact. For GxP organizations, the key is to handle those requirements not in isolation, but in step with existing GxP, QMS, CSV / CSA and Data Integrity structures.

Not just with a model you build yourself. AI features already embedded in SaaS, cloud, platform or supplier solutions can have GxP-relevant effects too, and need to be assessed accordingly.